Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Recruiting 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Non-Small-Cell Lung 88Breast Neoplasms 49Prostatic Neoplasms 43Squamous Cell Carcinoma of Head and Neck 34Lung Neoplasms 24Stomach Neoplasms 19Neoplasms 19Neoplasm Metastasis 17Head and Neck Neoplasms 17Parkinson Disease 4, Autosomal Dominant Lewy Body 14Urinary Bladder Neoplasms 13Carcinoma, Transitional Cell 11Triple Negative Breast Neoplasms 10Ovarian Neoplasms 8Endometrial Neoplasms 8Carcinoma, Squamous Cell 8Adenocarcinoma 8Non-Muscle Invasive Bladder Neoplasms 7HER2-positive Breast Cancer 7Prostatic Neoplasms, Castration-Resistant 6Melanoma 6Carcinoma 6Small Cell Lung Carcinoma 5Nasopharyngeal Carcinoma 5Esophageal Squamous Cell Carcinoma 5Esophageal Neoplasms 5Advanced Solid Tumors 5Uterine Cervical Neoplasms 4Sarcoma 4Oropharyngeal Neoplasms 4

Interventions

Cisplatin 26Paclitaxel 21pembrolizumab 15Radiotherapy 13Carboplatin 13tislelizumab 12Fluorouracil 12Drug Therapy 11Irinotecan 9toripalimab 8Esophagectomy 8Oxaliplatin 6Nivolumab 6Capecitabine 6Neoadjuvant Therapy 5Leucovorin 5Docetaxel 5lenvatinib 4camrelizumab 4Taxes 4Radiation 4Levoleucovorin 4Immune Checkpoint Inhibitors 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4spartalizumab 3sintilimab 3apatinib 3Itraconazole 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Docetaxel × 1 year × Clear all
NCT07621601 2026-06-02

A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Hansoh BioMedical R&D Company

Phase 3 Not yet recruiting
494 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis

NCT07463573 2026-04-24

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
466 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06304974 2026-04-17

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Active not recruiting
497 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06644781 2026-01-12

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Daiichi Sankyo

Phase 3 Recruiting
510 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05461794 2025-06-13

Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma

BeiGene

Phase 2 Terminated
96 enrolled 17 charts
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡